Developing the next generation of cancer vaccines

Irazu Oncology

  • Marco Chacon, PhD

    Founder & President

    Successful entrepreneur and former CEO and Chairman of Paragon Biosciences, Inc., a CDMO specialized in product development and GMP manufacturing of vaccines and viral vectors for gene therapy.

  • Marcio Chedid, PhD

    Chief Scientific Officer

    Experience in oncology small and large molecule drug discovery and clinical development. Former Executive Director of Biotechnology Discovery at Eli Lilly Co.

  • Kevin Chen, PhD

    Principal Scientist

    Background in microbiology and immunology. Expertise in disease modeling, antibody discovery and engineering and live vector delivery systems for vaccines and antibodies.

  • Brad Cawthern

    Director of Operations

    Background in GMP microbiology and IT. Expert in biopharma quality systems and bench -> plant -> patient project scalability with focus on safety and quality.